Cargando…

Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity

BACKGROUND: The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in microb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor-Cousar, Jennifer L., Zariwala, Maimoona A., Burch, Lauranell H., Pace, Rhonda G., Drumm, Mitchell L., Calloway, Hollin, Fan, Haiying, Weston, Brent W., Wright, Fred A., Knowles, Michael R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627933/ https://www.ncbi.nlm.nih.gov/pubmed/19169360 http://dx.doi.org/10.1371/journal.pone.0004270

Ejemplares similares

Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection
por: Pittman, Jessica E., et al.
Publicado: (2017)

Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013)

Mucin Variable Number Tandem Repeat Polymorphisms and Severity of Cystic Fibrosis Lung Disease: Significant Association with MUC5AC
por: Guo, XueLiang, et al.
Publicado: (2011)

Modifier genes and variation in cystic fibrosis
por: Drumm, Mitchell L
Publicado: (2001)

Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis
por: Henderson, Lindsay B., et al.
Publicado: (2012)

The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
por: Lommatzsch, Sherstin T., et al.
Publicado: (2019)

Novel variation at chr11p13 associated with cystic fibrosis lung disease severity
por: Dang, Hong, et al.
Publicado: (2016)

Management of pregnancy in cystic fibrosis
por: Montemayor, Kristina, et al.
Publicado: (2022)

Corrigendum: Novel variation at chr11p13 associated with cystic fibrosis lung disease severity
por: Dang, Hong, et al.
Publicado: (2017)

Genetic Influences on Cystic Fibrosis Lung Disease Severity
por: Weiler, Colleen A., et al.
Publicado: (2013)

CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis
por: Taylor-Cousar, Jennifer L.
Publicado: (2020)

Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
por: Shteinberg, Michal, et al.
Publicado: (2020)

Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Taylor-Cousar, Jennifer L, et al.
Publicado: (2010)

Family‐building and parenting considerations for people with cystic fibrosis
por: Kazmerski, Traci M., et al.
Publicado: (2021)

Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis
por: Sun, Lei, et al.
Publicado: (2012)

E-NTPDases in human airways: Regulation and relevance for chronic lung diseases
por: Burch, Lauranell H., et al.
Publicado: (2006)

Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population
por: Polineni, Deepika, et al.
Publicado: (2018)

Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis
por: West, Natalie E., et al.
Publicado: (2021)

Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction
por: Darrah, Rebecca, et al.
Publicado: (2017)

IFRD1 polymorphisms in cystic fibrosis with potential link to altered neutrophil function
por: Gu, YuanYuan, et al.
Publicado: (2009)

Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
por: Corvol, Harriet, et al.
Publicado: (2015)

Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population
por: Fedick, Anastasia M, et al.
Publicado: (2015)

Improving imputation in disease-relevant regions: lessons from cystic fibrosis
por: Panjwani, Naim, et al.
Publicado: (2018)

Histo-fisiología de la pulpa
por: Regalett Amador, Olivett
Publicado: (1988)

Quantitative Chemical Techniques of Histo- and Cytochemistry
por: Burt, Alvin M.
Publicado: (1964)

Cystic Fibrosis Mice Develop Spontaneous Chronic Bordetella Airway Infections
por: Darrah, R, et al.
Publicado: (2017)

Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del
por: Beswick, Daniel M., et al.
Publicado: (2022)

Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits
por: Vecchio-Pagán, Briana, et al.
Publicado: (2016)

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2
por: Wright, Fred A., et al.
Publicado: (2011)

Salivary Duct Cyst: Histo-pathologic Correlation
por: Vinayachandran, Divya, et al.
Publicado: (2013)

Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients
por: Sun, Quan, et al.
Publicado: (2022)

Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives
por: Narang, Kavita, et al.
Publicado: (2021)

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report
por: Levy, Hara, et al.
Publicado: (2010)

The Environmental Polymorphism Registry: A Unique Resource that Facilitates Translational Research of Environmental Disease
por: Chulada, Patricia C., et al.
Publicado: (2011)

Disociación histo-radiológica en fibrosis pulmonar secundaria a infección por SARS-CoV-2
por: Peiro Chamarro, M., et al.
Publicado: (2021)

A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
por: McHugh, Daniel R., et al.
Publicado: (2018)

Objective and patient‐based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy
por: Beswick, Daniel M., et al.
Publicado: (2022)

Studies on histoplasmosis IV. Elution characteristics of the Histo-inhibitory factor (HIF)
por: O'Hern, E. M., et al.
Publicado: (1968)

Norovirus Recognition Sites on Histo-Blood Group Antigens
por: Shirato, Haruko
Publicado: (2012)

Effects of Nano-particles on Histo-pathological changes of the fish
por: Monfared, Ali Louei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d0h4f6khbpou1nqa3rahg29k69